Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
Clinical trial NCT03035006 · TERMINATED
Trial details
- NCT number
- NCT03035006
- Sponsor
- Taiwan Liposome Company
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-14
- Primary completion
- 2018-10-31
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.